Yang, Guangjian
Xu, Haiyan
Yang, Yaning
Zhang, Shuyang
Xu, Fei
Hao, Xuezhi
Li, Junling
Xing, Puyuan
Hu, Xingsheng
Liu, Yutao
Wang, Lin
Lin, Lin
Wang, Zhijie
Duan, Jianchun
Wang, Jie
Wang, Yan
Funding for this research was provided by:
Beijing Health Promotion Association (2021-053-ZZ)
Article History
Received: 11 April 2022
Accepted: 8 July 2022
First Online: 29 August 2022
Declarations
:
: This study protocol was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (No.19–062/1847) in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Written informed consent was obtained from each participant before the onset of any trial-related treatment.
: Not applicable.
: The authors declare no competing interests.